Pancreatic Cancer Research

ResearcherKyushu UniversityActive in the last 2 years

Biao Zheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1905-2612; OpenAlex author ID A5103254572. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
41
Papers, trials and grants by year

2015: 2 papers · 2016: 3 papers · 2017: 3 papers · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 14

  1. Identification of a dihydroartemisinin-related prognostic signature and its contribution to cancer associated fibroblast of the tumor microenvironment of pancr… Last author DOI 10.1186/s12876-025-04241-y↗
  2. Effect of Bioactive Black Phosphorus Nanomaterials on Cancer-Associated Fibroblast Heterogeneity in Pancreatic Cancer. Co-author DOI 10.1021/acsnano.4c06147↗
  3. Identifying a baicalein-related prognostic signature contributes to prognosis prediction and tumor microenvironment of pancreatic cancer. Co-author DOI 10.3389/fimmu.2023.1223650↗
  4. PIK3CB is involved in metastasis through the regulation of cell adhesion to collagen I in pancreatic cancer. First author DOI 10.1016/j.jare.2021.02.002↗
  5. LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of Pancreatic Cancer. Co-author DOI 10.7150/thno.47001↗
  6. CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis. Co-author DOI 10.1007/s00432-019-02860-z↗
  7. Primary Recurrence in the Lung is Related to Favorable Prognosis in Patients with Pancreatic Cancer and Postoperative Recurrence. Co-author DOI 10.1007/s00268-017-4068-6↗
  8. Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mi… Co-author DOI 10.1053/j.gastro.2017.01.010↗
  9. Cancer-associated peritoneal mesothelial cells lead the formation of pancreatic cancer peritoneal dissemination. Co-author DOI 10.3892/ijo.2016.3829↗
  10. CD146 attenuation in cancer-associated fibroblasts promotes pancreatic cancer progression. Co-author DOI 10.1002/mc.22409↗
  11. Calpain inhibitor calpeptin suppresses pancreatic cancer by disrupting cancer-stromal interactions in a mouse xenograft model. Co-author DOI 10.1111/cas.13024↗
  12. Suppression of CD51 in pancreatic stellate cells inhibits tumor growth by reducing stroma and altering tumor-stromal interaction in pancreatic cancer. Co-author DOI 10.3892/ijo.2016.3374↗
  13. TM4SF1 as a prognostic marker of pancreatic ductal adenocarcinoma is involved in migration and invasion of cancer cells. Co-author DOI 10.3892/ijo.2015.3022↗
  14. Significance of expression of glucagon-like peptide 1 receptor in pancreatic cancer. Co-author DOI 10.3892/or.2015.4138↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zilong Yan · 6 shared papers, 2017–2025 · strength 0.86
  2. Kenoki Ohuchida · 10 shared papers, 2015–2021 · strength 0.68
  3. Takao Ohtsuka · 10 shared papers, 2015–2020 · strength 0.61
  4. Zhengquan Lai · 3 shared papers, 2023–2025 · strength 0.60
  5. Masafumi Nakamura · 7 shared papers, 2015–2021 · strength 0.50
  6. Jianhua Qu · 2 shared papers, 2024–2025 · strength 0.43
  7. Citing Zhang · 2 shared papers, 2023–2025 · strength 0.40
  8. Jikui Liu · 2 shared papers, 2023–2024 · strength 0.37
  9. Yoshinao Oda · 6 shared papers, 2015–2019 · strength 0.33
  10. Takashi Okumura · 5 shared papers, 2016–2019 · strength 0.32
  11. Yoshihiro Miyasaka · 5 shared papers, 2015–2019 · strength 0.28
  12. Makoto Hashizume · 4 shared papers, 2016–2019 · strength 0.24
  13. Jinglin Lai · 1 shared paper, 2025 · strength 0.23
  14. Peng Gong · 2 shared papers, 2020–2021 · strength 0.21
  15. Jianhua Qu · 2 shared papers, 2020–2021 · strength 0.21
  16. Kohei Horioka · 4 shared papers, 2016–2017 · strength 0.21
  17. Shengyong Geng · 1 shared paper, 2024 · strength 0.20
  18. Masafumi Nakamura · 3 shared papers, 2017–2019 · strength 0.19
  19. Kohei Nakata · 3 shared papers, 2017–2019 · strength 0.19
  20. Koji Shindo · 3 shared papers, 2015–2019 · strength 0.17
  21. Masafumi Sada · 3 shared papers, 2016–2017 · strength 0.16
  22. Masao Tanaka · 3 shared papers, 2015–2016 · strength 0.14
  23. Hiromichi Nakayama · 2 shared papers, 2017–2019 · strength 0.13
  24. Chika Iwamoto · 2 shared papers, 2017–2019 · strength 0.13
  25. Shin Takesue · 2 shared papers, 2017–2019 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.